Tatva Chintan Pharma Chem disclosed availability of its Q4 FY26 earnings call recording per SEBI LODR Regulation 46(2)(oa).
The earnings call was held on 16 May 2026 at 5:00 PM IST and is accessible via company website.
Disclosure made to BSE and NSE with scrip code 543321 through formal company secretary communication.